Showing results (31-40 of 136) with videos related to
Sort By:
Pageof 14
Arthritis and Rheumatism|February 1, 2011
MicroRNA expression profiles as biomarkers of minor salivary gland inflammation and dysfunction in Sjögren's syndromeIlias Alevizos, Stefanie Alexander, R James Turner, et al.The Biochemical Journal|September 1, 1992
Uptake of polyamines by human endothelial cells. Characterization and lack of effect of agonists of endothelial functionD M MorganMethods in Molecular Medicine|March 2, 2011
Isolation and culture of human umbilical vein endothelial cellsD M MorganThe Biochemical Journal|March 1, 1987
Oxidized polyamines and the growth of human vascular endothelial cells. Prevention of cytotoxic effects by selective acetylationD M MorganAnnals of the Rheumatic Diseases|August 2, 2006
Experience with experimental biological treatment and local gene therapy in Sjogren's syndrome: implications for exocrine pathogenesis and treatmentB M Lodde, B J Baum, P P Tak, et al.Nature Medicine|June 1, 2010
Basophils and the T helper 2 environment can promote the development of lupus nephritisNicolas Charles, Donna Hardwick, Eric Daugas, et al.Nature Clinical Practice. Rheumatology|November 1, 2006
Diagnosis and treatment of vasculitis of the central nervous system in a patient with systemic lupus erythematosusNikolay P Nikolov, Janine A Smith, Nicholas J Patronas, et al.Annals of the Rheumatic Diseases|February 9, 2018
Lupus Low Disease Activity State (LLDAS) attainment discriminates responders in a systemic lupus erythematosus trial: post-hoc analysis of the Phase IIb MUSE trial of anifrolumabEric F Morand, Teodora Trasieva, Anna Berglind, et al.Annals of the Rheumatic Diseases|May 26, 2010
Peptide-based ELISAs are not sensitive and specific enough to detect muscarinic receptor type 3 autoantibodies in serum from patients with Sjogren's syndromeN Roescher, A Kingman, Y Shirota, et al.Pageof 14